Key Points from the Announcement
- Extraordinary General Meeting (EGM) Scheduled: Sirnaomics Ltd. will hold an EGM on Tuesday, June 30, 2026, at 2:30 p.m. at Meeting Room 06–07, INNO2, 2/F, Building 17W, 17 Science Park West Avenue, Hong Kong Science Park, Shatin, New Territories, Hong Kong.
- Book Closure Period: The register of members will be closed from Thursday, June 25, 2026 to Tuesday, June 30, 2026 (both dates inclusive). During this period, no share transfers will be processed.
- Key Proposals at the EGM:
- Proposed termination of the existing 2022 RSU Scheme and adoption of a new 2026 RSU Scheme.
- Proposed termination of the existing 2022 Share Option Scheme and adoption of a new 2026 Share Option Scheme.
- Important deadline for shareholders: To be eligible to attend and vote at the EGM, shareholders must ensure all share transfer documents and relevant share certificates are submitted to the Company’s branch share registrar, Computershare Hong Kong Investor Services Limited, before 4:30 p.m. on Wednesday, June 24, 2026.
- Upcoming Circular: The company will send out the circular, EGM notice, and proxy form to shareholders in due course.
Details Investors Should Note
The EGM is being convened to vote on significant changes to the company’s long-term incentive frameworks—specifically, the replacement of both the RSU (Restricted Share Unit) and Share Option Schemes from their 2022 versions to new 2026 versions.
Potential Impact on Share Price: These changes may have material implications for shareholders and the company’s share price. The termination and adoption of new equity incentive schemes often signal changes in management incentives, employee retention strategies, and capital structure. Investors typically scrutinize such changes for potential dilution effects, alignment of management interests with shareholders, and potential impact on the company’s growth trajectory and share valuation.
Action Required: Shareholders intending to vote at the EGM must ensure their ownership is duly registered before the book closure period. Any failure to do so may result in loss of voting rights for this important meeting.
Next Steps: Detailed information about the new schemes and terms will be provided in the upcoming circular. Investors are strongly advised to review these materials when released.
Board Composition
- Chairman and Executive Director: Dr. Poon Hung Fai
- Non-Executive Director: Dr. Yin Huijun
- Independent Non-Executive Directors: Mr. Wong Yu Shan Eugene, Dr. Zhang Peng, Ms. Lo Yee Hang
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Investors should refer to official company documents and consult with their financial advisors before making any investment decisions. The information is based on public disclosures by Sirnaomics Ltd. and may be subject to change.
